A repeat Lp(a) measurement may allow more precise Lp(a)-specific cardiovascular risk prediction for individuals whose initial test result is in the intermediate ‘grey-zone’ as defined by the European Atherosclerosis Society guidelines.1,2
Please login or create a FREE account to view this content
Educational Partners and Supporters
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.(Founding Partner)